The Study of the Combination Therapeutic Effects of Ssri Antidepressants and Target Therapy Medications on Braf Inhibitor-Resistant Melanoma

Project: A - Government Institution › b - National Science and Technology Council

Project Details

StatusFinished
Effective start/end date8/1/19 → 7/31/20

Keywords

  • BRAF-WT melanoma
  • BRAF mutation melanoma；
  • Drug-resistance melanoma
  • SSRI antidepressant
  • Combination therapy

Access Project